Henry Review Pension Age Debate Unpopular But Necessary, Say Seniors - Australia Despite floating controversial ideas such as raising the Age Pension age, older Australians have welcomed the debate unfolding around the sustainability of the retirement income system. In a community consultation paper released today, the Future Tax System or Henry Review reveals raising the Age Pension age (65) is just one of the suggestions received in the first round of public submissions.
Source: www.medicalnewstoday.comRoad Fuel Supply - NPA Works With DH To Put Pharmacy In NHS Guidance, UK The NPA has worked with the Department of
Health's Emergency Preparedness Division to consider what PCTs should be doing to support community pharmacies in the event of significant disruption to the supply of road fuel - such as the recent tanker drivers' strike - and enable them to have access to road fuel to undertake necessary roles. As a result there are numerous references to community pharmacy in the newly published NHS Guidance on Planning for Disruption to Road Fuel Supply.
Source: www.medicalnewstoday.comITI Announces New Progress Milestones In Its Development Program For Acute Repetitive Seizure In Epilepsy ITI, a privately held specialty pharmaceutical company, today announced that the company has achieved several important developments in its epilepsy product program, including - Receipt of Fast Track Designation from the U.S.
Source: www.medicalnewstoday.comAstraZeneca And Targacept Announce Top-Line Results From Phase IIb Study Of AZD3480 In Cognitive Dysfunction In Schizophrenia AstraZeneca (NYSE: AZN) and Targacept, Inc. (NASDAQ: TRGT) today announced top-line results from a Phase IIb clinical trial of AZD3480 (TC-1734) conducted by AstraZeneca in cognitive dysfunction in schizophrenia (CDS), known as the HALO trial.
Source: www.medicalnewstoday.comZIOPHARM Presents Positive Darinaparsin Phase II Data At ASH Meeting ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that on December 6th it presented positive data from a Phase II study of darinaparsin (ZinaparTM) for the treatment of advanced lymphomas at the 50th American Society of Hematology (ASH) Annual Meeting held in San Francisco, CA.
Source: www.medicalnewstoday.comDangerous Side Effect For Lymphoma Patients Prevented By New Therapy Patients respond well to a new three-drug combination for indolent B cell lymphoma that also spares them prolonged, potentially lethal, suppression of blood production in the bone marrow, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 50th annual meeting of the American Society of Hematology.
Source: www.medicalnewstoday.comGender Gap In Spatial Skills Starts In Infancy Men tend to perform better than women at tasks that require rotating an object mentally, studies have indicated. Now, developmental psychologists at Pitzer College and UCLA have discovered that this type of spatial skill is present in infancy and can be found in boys as young as 5 months old.
Source: www.medicalnewstoday.comDynavax Presents Preclinical Data Supporting Its Novel Universal Flu Vaccine Candidate Dynavax Technologies Corporation (Nasdaq:DVAX) announced today preclinical data showing results from a key component of the Company's novel Universal Flu vaccine candidate.
Source: www.medicalnewstoday.comClinical Studies Identify Oral Drug As Promising Future Treatment For Patients With Rare Subtype Of Non-Hodgkin Lymphoma Lenalidomide, an oral drug targeting the immune system, appears to have promise as a novel future treatment for patients with relapsed or refractory mantle-cell lymphoma, according to a study led by Myron S. Czuczman, MD, Department of
Medicine, Roswell Park Cancer Institute (RPCI).
Source: www.medicalnewstoday.com
# posted by Network @ 4:00 PM
